Telephone Based Cognitive Behavioral Therapy for HIV Related Depression

Sponsor
University of Maryland, Baltimore (Other)
Overall Status
Completed
CT.gov ID
NCT01055158
Collaborator
National Institute of Mental Health (NIMH) (NIH), University of Maryland, College Park (Other)
38
1
2
24
1.6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effectiveness of a telephone-based, cognitive behavioral therapy intervention in the treatment of depression in adults diagnosed with HIV.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Telephone-based CBT
  • Behavioral: Enhanced Usual Care
N/A

Detailed Description

Up to 40% of individuals receiving medical care for HIV meet DSM-IV criteria for co-occurring depressive disorder. Individuals with HIV and depressive disorders, compared to those with HIV alone, have been shown to have worse adherence to taking antiretroviral medication, increased HIV related morbidity and among women a higher mortality. Previous research suggests that mental health interventions may lead to improved depressive and HIV related outcomes. However because many HIV infected depressed individuals may have trouble accessing mental health services, there is an urgent need for treatment trials to assess whether treatment of depression targeting patients in urban HIV care settings will result in both improved depressive and HIV related outcomes. The goal of this project is to test the preliminary effectiveness of an adapted telephone-based, cognitive behavioral therapy (CBT) intervention targeting HIV infected depressed individuals receiving care in adult outpatient HIV clinics. A total of 60 HIV infected, depressed individuals receiving care at an urban, outpatient HIV clinic will be randomly assigned to receive either the telephone psychotherapy intervention or enhanced usual care with non-specific telephone contact. The results will provide preliminary data on whether the telephone psychotherapy intervention for HIV infected depressed individuals is effective in reducing depression. The results will also be used to determine feasibility, accessibility, and whether the intervention leads to improved retention and better satisfaction.

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Connect: A Pilot Study of Telephone Based Cognitive Behavioral Therapy for HIV Related Depression
Study Start Date :
Jan 1, 2010
Actual Primary Completion Date :
Jan 1, 2012
Actual Study Completion Date :
Jan 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telephone-based CBT

A form of CBT delivered over the telephone by a trained, licensed, master's or doctoral level clinician. The intervention consists of approximately 10 sessions conducted over approximately 14 weeks. Each session is approximately 30 to 50 minutes.

Behavioral: Telephone-based CBT
A form of CBT delivered over the telephone by a trained, licensed, master's or doctoral level clinician. The intervention consists of approximately 10 sessions conducted over approximately 14 weeks. Each session is approximately 30 to 50 minutes. All sessions begin with a depression rating and agenda setting and end with task assignments and summaries.
Other Names:
  • CONNECT
  • Active Comparator: Control

    Enhanced Usual Care

    Behavioral: Enhanced Usual Care
    Participants randomized to this condition will be referred to receive in-person psychotherapy. Research study staff will help participants to set up their first appointment with a psychotherapist.

    Outcome Measures

    Primary Outcome Measures

    1. Hamilton Depression Scale (HAM-D) [Baseline, Week 8, Week 16]

    2. The Quick Inventory of Depressive Symptomatology (16-Item) (Self-Report) (QIDS-SR16) [Baseline, Week 8, Week 16]

    Secondary Outcome Measures

    1. Provision of Social Relationships (PSR) [Baseline, Week 8, Week 16]

    2. Brief COPE [Baseline, Week 8, Week 16]

    3. SF-12 Health Survey [Baseline, Week 8, Week 16]

    4. Therapist Adherence [Week 1-14]

    5. Participant Adherence to Treatment [Week 1-14]

    6. Working Alliance Inventory [Week 8, Week 16]

    7. Satisfaction Index- Mental Health (SIMH-PW) [Week 8, Week 16]

    8. Expectancy Scales [Week 8, Week 16]

    9. Adherence to Highly Active Antiretroviral Therapy (HAART) [Baseline, Week 15]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Has a DSM-IV diagnosis of a Depressive Disorder as measured by the mood battery of the MINI

    • Has a diagnosis of HIV and is receiving HIV related outpatient care at the Evelyn Jordan Center in Baltimore, MD

    • Is able to speak English

    • Is able to read English on approximately the 6th grade reading level or higher as measured by the Wide Range Achievement Test 4 (WRAT-4) or by self-report

    • Is at least 18 years old

    • Has access to a telephone

    Exclusion Criteria:
    • Meets criteria for dementia by scoring below 10 on the Hopkins HIV Dementia Scale

    • Shows signs of serious psychiatric pathology that might either be due to an organic etiology other than HIV, or would generally not be considered treatable solely with psychotherapy, or for whom participation in this protocol might be considered dangerous or unethical

    • has a history of serious suicide attempts or is severely suicidal (has ideation, plan, and intent) determined by the MINI

    • Patients in psychotherapy are excluded because it is confounded with the study treatments

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Maryland Medical Center, Evelyn Jordan Center Baltimore Maryland United States 21201

    Sponsors and Collaborators

    • University of Maryland, Baltimore
    • National Institute of Mental Health (NIMH)
    • University of Maryland, College Park

    Investigators

    • Principal Investigator: Seth S Himelhoch, M.D., M.P.H, University of Maryland, College Park

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Maryland, Baltimore
    ClinicalTrials.gov Identifier:
    NCT01055158
    Other Study ID Numbers:
    • HP-00043648
    • R34MH080630
    First Posted:
    Jan 25, 2010
    Last Update Posted:
    May 11, 2021
    Last Verified:
    May 1, 2021
    Keywords provided by University of Maryland, Baltimore
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 11, 2021